# A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

> **NCT07073417** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Hangzhou Sciwind Biosciences Co., Ltd.** · enrollment: 163 (actual)

## Conditions studied

- Obesity
- Weight Management

## Interventions

- **DRUG:** XW003 injection
- **DRUG:** semaglutide injection

## Key facts

- **NCT ID:** NCT07073417
- **Lead sponsor:** Hangzhou Sciwind Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-28
- **Primary completion:** 2027-02-27
- **Final completion:** 2027-08-23
- **Target enrollment:** 163 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073417, "A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07073417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*